Related Experiment Video
Updated: Sep 27, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Management of Head and Neck Mucosal Melanoma
Pablo Nenclares1, Kevin J Harrington1
1Head and Neck Unit, The Royal Marsden Hospital, London, UK; Division of Radiotherapy and Imaging, Targeted Therapy Team, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, United Kingdom.
Abstract:
Head and neck mucosal melanomas are uncommon and aggressive malignancies that arise mainly in the nasal cavity and paranasal sinuses, with the next commonest site being the oral cavity. The mainstay of treatment is radical surgical resection. Adjuvant radiotherapy improves locoregional control but does not improve overall survival. Systemic treatment with immunotherapy or targeted therapies can offer scope for modifying the course of the disease in both the adjuvant and the recurrent and metastatic setting. Further understanding of the genomic landscape and factors regulating immunogenicity will lead to further therapeutic opportunities in this challenging disease.

